N/A
N=99
PainTracker Self-Manager: a Web-based Platform to Promote and Track Chronic Pain Self-management
Chronic Pain
Bottom Line
View on ClinicalTrials.gov: NCT03045081 ↗Enrolled (actual)
99
Serious AEs
0.0%
Results posted
Nov 2019
Primary outcome: Primary: Chronic Pain Self-efficacy — 27.33; 33.66; 28.39; 35.57 score on a scale — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- PainTracker Self-Manager (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Sep 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Chronic Pain Self-efficacy |
27.33; 33.66; 28.39; 35.57 | <0.05 sig |
| SECONDARY Chronic Pain Acceptance |
31.05; 36.36; 32.91; 38.00; 20.69; 23.06 | 0.068 |
| SECONDARY Patient-physician Interactions |
17.53; 19.22; 17.75; 20.03 | 0.176 |
| SECONDARY Patient Satisfaction |
5.07; 5.39; 5.27; 6.36 | <0.05 sig |
| SECONDARY Provider Satisfaction |
— | — |
| SECONDARY Pain Severity, Enjoyment of Life Interference, General Activity Interference (PEG) |
6.83; 6.06; 6.51; 6.06 | 0.102 |
Summary
To develop and test a web-based patient empowerment platform, PainTracker Self-Manager (PTSM), that can support integrated multimodal care in a variety of specialty and primary care settings. The investigators will adapt PainTracker, a web-based outcome and treatment tracking tool already deployed in multiple University of Washington clinics to create the PTSM self-management tool that helps assess, engage, activate, and support patients' efforts to self-manage their chronic pain in collaboration with their clinicians. PTSM design will be based on 4-phase patient engagement strategy derived from Acceptance and Commitment Therapy. Phase 1 focuses on achieving consensus on the clinical problem definition, treatment goals and timeline. Phase 2 focuses on promoting values-based action and acceptance of pain. Phase 3 focuses on providing skills in chronic pain self-management with close monitoring of patient reported outcomes and actigraphy. Phase 4 focuses on providing autonomy support to promote maintenance of self-management behaviors. Phase 5 involves generating a patient registry with the above data for use in quality improvement research. The investigators will engage patients, providers and investigators in designing PTSM, reviewing prototypes, and conducting usability testing. In a 6-month clinical trial, the investigators will compare 50 intervention patients from the UW Center for Pain Relief who receive PTSM to 50 historical control patients who have received the basic PainTracker. The primary outcome will be chronic pain self-efficacy, with secondary outcomes of: chronic pain acceptance, perceived efficacy in physician-patient interactions, and patient and provider satisfaction. Development of the PTSM platform will support the dissemination of the multimodal interdisciplinary care for chronic pain that is recommended in the National Pain Strategy, and may help chronic pain care meet the goals of the Triple Aim: better patient experience, better patient outcomes, with lower costs.
Eligibility Criteria
Inclusion Criteria
- All new patients receiving care at University of Washington's Center for Pain Relief (UWCPR) and planning ongoing pain care by providers at UWCPR (not one-time consults or procedure patients), with a diagnosis of one or more chronic pain disorders
- *Note: Eligible patients will be invited to participate in the study after completing their second PainTracker pre-UWCPR visit assessment.
Exclusion Criteria
- Patients attending UWCPR for only a single session or for only evaluation
- Patients participating in 6-week Pain Support Groups at UWCPR or Harborview Medical Center for the duration of the 6-month study
- Unable to read and write English
- Dementia or other significant cognitive impairment
Data sourced from ClinicalTrials.gov (NCT03045081). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.